Bloomage Biotechnology Corp Ltd
SSE:688363
Bloomage Biotechnology Corp Ltd
Cash from Investing Activities
Bloomage Biotechnology Corp Ltd
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Bloomage Biotechnology Corp Ltd
SSE:688363
|
Cash from Investing Activities
-ÂĄ540.4m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
||
Beigene Ltd
HKEX:6160
|
Cash from Investing Activities
ÂĄ117.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Innovent Biologics Inc
HKEX:1801
|
Cash from Investing Activities
-ÂĄ2.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
||
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Investing Activities
-ÂĄ2.1B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
||
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Investing Activities
-ÂĄ1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-18%
|
||
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Investing Activities
-ÂĄ1.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-102%
|
CAGR 10-Years
N/A
|
Bloomage Biotechnology Corp Ltd
Glance View
Nestled in the bustling corridors of the biotechnology industry, Bloomage Biotechnology Corp Ltd. has carved a niche as a leading player specializing in the production and innovation of biopolymers, with a particular emphasis on hyaluronic acid. Since its inception, the company has embraced a scientific approach combined with a robust business strategy, propelling it to the forefront of biotechnological advancements. Its operations are underpinned by a relentless pursuit of research and development, utilizing cutting-edge fermentation technology to manufacture high-quality hyaluronic acid that serves various industries such as cosmetics, food, and pharmaceuticals. Bloomage’s revenue model is intricately linked to the diverse applications of hyaluronic acid. By supplying raw materials to cosmetic giants, the company significantly taps into the lucrative beauty industry, as this compound is highly valued for its skin hydration properties. Additionally, Bloomage is involved in the healthcare segment, where it provides key ingredients for medical products that enhance joint health and accelerate wound healing. Through strategic partnerships and a focus on high-margin products, Bloomage not only diversifies its revenue streams but also sustains its position in competitive markets. This deliberate orchestration of science and commerce ensures the company remains at the vanguard of both innovation and profitability.
See Also
What is Bloomage Biotechnology Corp Ltd's Cash from Investing Activities?
Cash from Investing Activities
-540.4m
CNY
Based on the financial report for Sep 30, 2024, Bloomage Biotechnology Corp Ltd's Cash from Investing Activities amounts to -540.4m CNY.
What is Bloomage Biotechnology Corp Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-28%
Over the last year, the Cash from Investing Activities growth was -34%. The average annual Cash from Investing Activities growth rates for Bloomage Biotechnology Corp Ltd have been 16% over the past three years , -28% over the past five years .